Cyclooxygenase-2 catalysis and inhibition in lipid bilayer nanodiscs
- PMID: 24503478
- PMCID: PMC3967765
- DOI: 10.1016/j.abb.2014.01.026
Cyclooxygenase-2 catalysis and inhibition in lipid bilayer nanodiscs
Abstract
Cyclooxygenases (COX-1 and COX-2) oxygenate arachidonic acid (AA) to generate prostaglandins. The enzymes associate with one leaflet of the membrane bilayer. We utilized nanodisc technology to investigate the function of human (hu) COX-2 and murine (mu) COX-2 in a lipid bilayer environment. huCOX-2 and muCOX-2 were incorporated into nanodiscs composed of POPC, POPS, DOPC, or DOPS phospholipids. Size-exclusion chromatography and negative stain electron microscopy confirm that a single COX-2 homodimer is incorporated into the nanodisc scaffold. Nanodisc-reconstituted COX-2 exhibited similar kinetic profiles for the oxygenation of AA, eicosapentaenoic acid, and 1-arachidonoyl glycerol compared to those derived using detergent solubilized enzyme. Moreover, changing the phospholipid composition of the nanodisc did not alter the ability of COX-2 to oxygenate AA or to be inhibited by various nonselective NSAIDs or celecoxib. The cyclooxygenase activity of nanodisc-reconstituted COX-2 was reduced by aspirin acetylation and potentiated by the nonsubstrate fatty acid palmitic acid to the same extent as detergent solubilized enzyme, independent of phospholipid composition. The stabilization and maintenance of activity afforded by the incorporation of the enzyme into nanodiscs generates a native-like lipid bilayer environment to pursue studies of COX utilizing solution-based techniques that are otherwise not tractable in the presence of detergents.
Keywords: Arachidonic acid; Aspirin; Cyclooxygenase; Nanodisc; Nonsteroidal anti-inflammatory drugs; Phospholipid.
Copyright © 2014 Elsevier Inc. All rights reserved.
Figures







Similar articles
-
Crystal Structure of Aspirin-Acetylated Human Cyclooxygenase-2: Insight into the Formation of Products with Reversed Stereochemistry.Biochemistry. 2016 Mar 1;55(8):1226-38. doi: 10.1021/acs.biochem.5b01378. Epub 2016 Feb 19. Biochemistry. 2016. PMID: 26859324 Free PMC article.
-
Arg-513 and Leu-531 Are Key Residues Governing Time-Dependent Inhibition of Cyclooxygenase-2 by Aspirin and Celebrex.Biochemistry. 2019 Sep 24;58(38):3990-4002. doi: 10.1021/acs.biochem.9b00659. Epub 2019 Sep 9. Biochemistry. 2019. PMID: 31469551 Free PMC article.
-
A mechanistic hypothesis for the aspirin-induced switch in lipid mediator production by cyclooxygenase-2.J Am Chem Soc. 2013 Jul 17;135(28):10404-10. doi: 10.1021/ja402870k. Epub 2013 Jul 5. J Am Chem Soc. 2013. PMID: 23786234
-
Nanodiscs for Structural Biology in a Membranous Environment.Chem Pharm Bull (Tokyo). 2019;67(4):321-326. doi: 10.1248/cpb.c18-00941. Chem Pharm Bull (Tokyo). 2019. PMID: 30930435 Review.
-
Computer aided drug design approaches to develop cyclooxygenase based novel anti-inflammatory and anti-cancer drugs.Curr Pharm Des. 2007;13(34):3505-17. doi: 10.2174/138161207782794275. Curr Pharm Des. 2007. PMID: 18220787 Review.
Cited by
-
Polymorphisms of CYP2C8 Alter First-Electron Transfer Kinetics and Increase Catalytic Uncoupling.Int J Mol Sci. 2019 Sep 18;20(18):4626. doi: 10.3390/ijms20184626. Int J Mol Sci. 2019. PMID: 31540428 Free PMC article.
-
Recent advances in nanodisc technology for membrane protein studies (2012-2017).FEBS Lett. 2017 Jul;591(14):2057-2088. doi: 10.1002/1873-3468.12706. Epub 2017 Jul 6. FEBS Lett. 2017. PMID: 28581067 Free PMC article. Review.
-
Nanodiscs in Membrane Biochemistry and Biophysics.Chem Rev. 2017 Mar 22;117(6):4669-4713. doi: 10.1021/acs.chemrev.6b00690. Epub 2017 Feb 8. Chem Rev. 2017. PMID: 28177242 Free PMC article. Review.
-
Enhanced imaging of lipid rich nanoparticles embedded in methylcellulose films for transmission electron microscopy using mixtures of heavy metals.Micron. 2017 Aug;99:40-48. doi: 10.1016/j.micron.2017.03.019. Epub 2017 Apr 10. Micron. 2017. PMID: 28419915 Free PMC article.
-
Endocannabinoids anandamide and 2-arachidonoylglycerol are substrates for human CYP2J2 epoxygenase.J Pharmacol Exp Ther. 2014 Dec;351(3):616-27. doi: 10.1124/jpet.114.216598. Epub 2014 Oct 2. J Pharmacol Exp Ther. 2014. PMID: 25277139 Free PMC article.
References
-
- Blobaum AL, Marnett LJ. Structural and functional basis of cyclooxygenase inhibition. J Med Chem. 2007;50:1425–1441. - PubMed
-
- DeWitt DL. Cox-2-selective inhibitors: the new super aspirins. Mol Pharmacol. 1999;55:625–631. - PubMed
-
- Garavito RM, Malkowski MG, DeWitt DL. The structures of prostaglandin endoperoxide H synthases-1 and -2. Prostaglandins Other Lipid Mediat. 2002;68–69:129–152. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials